@article {Mintz2020.10.30.20222695, author = {Carrie M. Mintz and Sarah M. Hartz and Sherri L. Fisher and Alex T. Ramsey and Elvin H. Geng and Richard A. Grucza and Laura J. Bierut}, title = {A Cascade of Care for Alcohol Use Disorder: Using 2015-2018 National Survey on Drug Use and Health Data to Identify Gaps in Care}, elocation-id = {2020.10.30.20222695}, year = {2020}, doi = {10.1101/2020.10.30.20222695}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {Background Although effective treatments exist, alcohol use disorder (AUD) is undertreated. We used a cascade of care framework to understand gaps in care between diagnosis and treatment for persons with AUD.Methods Using 2015-2018 National Survey on Drug Use and Health data, we evaluated the following steps in the cascade of care: 1) prevalence of adults with AUD; 2) proportion of adults who utilized health care in the past 12 months; 3) were screened about alcohol use; 4) received a brief intervention about alcohol misuse; 5) received information about treatment for alcohol misuse; and 6) proportion of persons with AUD who received treatment. Analyses were stratified by AUD severity.Results Of the 171,766 persons included in the sample, weighted prevalence of AUD was 7.9\% (95\% CI 7.7-8.0\%). Persons with AUD utilized health care settings at similar rates as those without AUD. Cascades of care showed the majority of individuals with AUD utilized health care and were screened about alcohol use, but the percent who received the subsequent steps of care decreased substantially. For those with severe AUD, 83.5\% (CI: 78.3\%-88.7\%) utilized health care in the past 12 months, 73.5\% (CI: 68.1\%-78.9\%) were screened for alcohol use, 22.7\% (CI: 19.4\%-26.0\%) received a brief intervention, 12.4\% (CI: 10\%-14.7\%) received information about treatment, and 20.5\% (CI: 18\%-23.1\%) were treated for AUD. The greatest decrease in the care continuum occurred from screening to brief intervention and referral to treatment. More persons with severe AUD received treatment than were referred, indicating other pathways to treatment outside of the healthcare system.Conclusions Persons with AUD utilize health care at high rates and are frequently screened about alcohol use, but few receive treatment. Health care settings-particularly primary care settings-represent a prime opportunity to implement pharmacologic treatment for AUD to improve outcomes in this high-risk population.Competing Interest StatementLJB is listed as an inventor on Issued U.S. Patent 8,080,371,Markers for Addiction, covering the use of certain SNPs in determining the diagnosis, prognosis, and treatment of addiction. Dr. Bierut is a Speaker Bureau member for Imedex. The other authors report no conflict of interest.Clinical TrialN/A.Funding StatementThis work was supported by National Institute on Drug Abuse grants K12 DA041449 (CMM, LJB, SLF, ATK), R21 DA044744 (RAG); National Institute on Alcohol Abuse and Alcoholism grants R21 AA025689 (RAG) and R01 AA029308 (SMH); National Institute of Allergy and Infectious Diseases grant K24 AI134413 (EHG); and Substance Abuse and Mental Health Services Administration H79TI082566 (CMM, SMH).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was determined to be non-human subjects and thus was exempted from review by the IRB at Washington University.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData were from the 2015-2018 National Surveys on Drug Use and Health, which are publically available. https://www.datafiles.samhsa.gov/study/national-survey-drug-use-and-health-nsduh-2002-2018-nid18771}, URL = {https://www.medrxiv.org/content/early/2020/11/04/2020.10.30.20222695}, eprint = {https://www.medrxiv.org/content/early/2020/11/04/2020.10.30.20222695.full.pdf}, journal = {medRxiv} }